Its came away long way since 2013 without digging into shareholders pockets with ongoing dilution , and now cash postive ,entering biggest health system on a approved FDA and next China ...etc.
Making more cash postive then MSB , and cheaper then RAP and BIT .
Also a massive organic growth potential here.
Yet only a Mcap of $30m ,Work that out ?
Its came away long way since 2013 without digging into...
-
- There are more pages in this discussion • 2,515 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
